Tumour exosome integrins determine organotropic metastasis A Hoshino, B Costa-Silva, TL Shen, G Rodrigues, A Hashimoto, ... Nature 527 (7578), 329-335, 2015 | 4622 | 2015 |
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET H Peinado, M Alečković, S Lavotshkin, I Matei, B Costa-Silva, ... Nature medicine 18 (6), 883-891, 2012 | 3910 | 2012 |
A multigenic program mediating breast cancer metastasis to bone Y Kang, PM Siegel, W Shu, M Drobnjak, SM Kakonen, C Cordón-Cardo, ... Cancer cell 3 (6), 537-549, 2003 | 3163 | 2003 |
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 M Korpal, ES Lee, G Hu, Y Kang Journal of Biological Chemistry 283 (22), 14910-14914, 2008 | 1992 | 2008 |
Epithelial-mesenchymal transitions: twist in development and metastasis Y Kang, J Massagué Cell 118 (3), 277-279, 2004 | 1941 | 2004 |
Pre-metastatic niches: organ-specific homes for metastases H Peinado, H Zhang, IR Matei, B Costa-Silva, A Hoshino, G Rodrigues, ... Nature Reviews Cancer 17 (5), 302-317, 2017 | 1659 | 2017 |
Guidelines and definitions for research on epithelial–mesenchymal transition J Yang, P Antin, G Berx, C Blanpain, T Brabletz, M Bronner, K Campbell, ... Nature reviews Molecular cell biology 21 (6), 341-352, 2020 | 1472 | 2020 |
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors AJ Minn, Y Kang, I Serganova, GP Gupta, DD Giri, M Doubrovin, ... The Journal of clinical investigation 115 (1), 44-55, 2005 | 942 | 2005 |
Beyond tumorigenesis: cancer stem cells in metastasis F Li, B Tiede, J Massagué, Y Kang Cell research 17 (1), 3-14, 2007 | 871 | 2007 |
Extracellular vesicle and particle biomarkers define multiple human cancers A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ... Cell 182 (4), 1044-1061. e18, 2020 | 869 | 2020 |
Tumor metastasis: moving new biological insights into the clinic L Wan, K Pantel, Y Kang Nature medicine 19 (11), 1450-1464, 2013 | 816 | 2013 |
Hypoxia and hypoxia-inducible factors: master regulators of metastasis X Lu, Y Kang Clinical cancer research 16 (24), 5928-5935, 2010 | 802 | 2010 |
Epithelial-mesenchymal plasticity in cancer progression and metastasis W Lu, Y Kang Developmental cell 49 (3), 361-374, 2019 | 784 | 2019 |
A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells Y Kang, CR Chen, J Massagué Molecular cell 11 (4), 915-926, 2003 | 757 | 2003 |
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization M Korpal, BJ Ell, FM Buffa, T Ibrahim, MA Blanco, T Celià-Terrassa, ... Nature medicine 17 (9), 1101-1108, 2011 | 718 | 2011 |
E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression CR Chen, Y Kang, PM Siegel, J Massagué Cell 110 (1), 19-32, 2002 | 673 | 2002 |
Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells N Sethi, X Dai, CG Winter, Y Kang Cancer cell 19 (2), 192-205, 2011 | 665 | 2011 |
Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway Y Kang, W He, S Tulley, GP Gupta, I Serganova, CR Chen, ... Proceedings of the National Academy of Sciences 102 (39), 13909-13914, 2005 | 638 | 2005 |
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors X Lu, E Mu, Y Wei, S Riethdorf, Q Yang, M Yuan, J Yan, Y Hua, BJ Tiede, ... Cancer cell 20 (6), 701-714, 2011 | 556 | 2011 |
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer G Hu, RA Chong, Q Yang, Y Wei, MA Blanco, F Li, M Reiss, JLS Au, ... Cancer cell 15 (1), 9-20, 2009 | 514 | 2009 |